focus -WSS

focus

author：entertainment 2025-10-02 01:09:07 - browse：315

Sutter Health Palo Alto Medical Foundation facilities. health tech coverage from STAT — Adobe

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for example, how its former finance chief said the system would make an extra $200 million per year by making insurers contract with all of its hospitals instead of just a few. Or how its former CEO said, “Related to the health plans, we force them to pay us more.”

That evidence was indeed relevant, and the judge erred by not allowing it to be presented during the month-long trial that concluded in March 2022, a U.S. appeals court wrote in its ruling on Tuesday. The Ninth Circuit panel overturned Sutter’s win in the class-action case alleging that Sutter used its market power to drive up health care costs across the region by more than $400 million. Tuesday’s decision means the case will likely get a second trial.

“Effectively, the appellate court said the jury was tainted,” said Matthew Cantor, lead counsel for the plaintiffs. “So the jury’s verdict is discarded.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： The biotech scorecard for Q1: 17 stock

focus

entertainment

WSS

National associations that represent hospice owe an apology

As obesity drug market grows, telehealth companies court payers

Federal weight loss drug coverage is 30 years out of date

Health officials lay out plans to cope with respiratory virus season

Feng Zhang CRISPR delivery startup lays off quarter of staff

Health officials lay out plans to cope with respiratory virus season

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

JPM: CVS says Medicare Advantage patients are impacting profits

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New weight loss drugs work. But how can they best be used?

Bright Health sells Medicare Advantage business to Molina

Wegovy improves function in certain heart failure patients

Tori Bowie and the unacceptable rates of Black maternal death

UCB departs biotech trade group BIO

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Health officials lay out plans to cope with respiratory virus season

hotspot

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Feng Zhang, Grail founder join forces on new gene editing startup

How the first Native Hawaiian psychiatrist helped diversify medicine

Why psychiatrists like me stop taking insurance

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Federal weight loss drug coverage is 30 years out of date

focus

focus

entertainment

focus